We also analyzed the PSMC2 in the hub gene and found that overexpression of PSMC2 in various cancers is associated with poor prognosis, clarified its value as a prognostic factor and therapeutic target for renal cancer. This evidence concerns the gene PSMC2 and renal carcinoma.